Darcalma Interactions
There are 754 drugs known to interact with Darcalma (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate), along with 37 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 256 are major, 483 are moderate, and 15 are minor.
- View all 754 medications that may interact with Darcalma
- View Darcalma alcohol/food interactions (3)
- View Darcalma disease interactions (37)
Most frequently checked interactions
View interaction reports for Darcalma (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Align (bifidobacterium infantis)
- Ambien CR (zolpidem)
- amphetamine
- Boniva (ibandronate)
- buprenorphine
- buprenorphine / naloxone
- bupropion
- Cymbalta (duloxetine)
- diazepam
- Effexor XR (venlafaxine)
- Elmiron (pentosan polysulfate sodium)
- hydrocodone
- hydroxyzine
- lisinopril
- Lunelle (estradiol / medroxyprogesterone)
- Lunesta (eszopiclone)
- Lyrica (pregabalin)
- Midrin (acetaminophen / dichloralphenazone / isometheptene mucate)
- nabumetone
- Nora-Be (norethindrone)
- Nucynta (tapentadol)
- Orencia (abatacept)
- Premarin (conjugated estrogens)
- promethazine
- ranitidine
- Vicodin (acetaminophen / hydrocodone)
- vitamin e
- Wellbutrin SR (bupropion)
- Xanax XR (alprazolam)
Darcalma alcohol/food interactions
There are 3 alcohol/food interactions with Darcalma (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate).
Darcalma disease interactions
There are 37 disease interactions with Darcalma (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- inflammatory bowel disease
- intestinal obstruction disorders
- crystalluria
- gout
- liver disease
- methemoglobinemia in G-6-PD
- hypocalcemia
- phosphate imbalance
- GI toxicity
- renal dysfunction
- Reye's syndrome
- electrolyte imbalance
- cardiac disease
- tachycardia
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- liver disease
- renal failure
- renal dysfunction
- anemia
- coagulation
- dialysis
- G-6-PD deficiency
- hepatotoxicity
- hypertension
- hyperthyroidism
- diarrhea
- fever
More about Darcalma (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.